Breast Cancer Res Treat 2019 Feb
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
Related Questions
New answer by Medical Oncologist at H Lee Moffitt Cancer Center, University of South Florida (July 8, 2019)
The data from the PROGECT study using neoadjvuant carboplatin/docetaxel in TNBC suggests that they do well when they attain a pCR without giving an anthracycline. (S...